Operating Income (Loss) in USD of Silence Therapeutics plc from 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Silence Therapeutics plc quarterly/annual Operating Income (Loss) history and change rate from 2022 to Q3 2025.
  • Silence Therapeutics plc Operating Income (Loss) for the quarter ending September 30, 2025 was -$26.2M, a 12.5% increase year-over-year.
  • Silence Therapeutics plc Operating Income (Loss) for the twelve months ending September 30, 2025 was -$83M.
  • Silence Therapeutics plc annual Operating Income (Loss) for 2024 was -$63.3M, a 1.65% increase from 2023.
  • Silence Therapeutics plc annual Operating Income (Loss) for 2023 was -$64.4M, a 5.48% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Silence Therapeutics plc Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$83M -$26.2M +$3.75M +12.5% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$86.7M -$24M -$575K -2.46% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$86.1M -$28.4M -$22.8M -409% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 -$63.3M -$4.35M Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$30M Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 -$23.4M Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 -$5.58M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08

Silence Therapeutics plc Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$63.3M +$1.06M +1.65% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 -$64.4M -$3.34M -5.48% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 -$61M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.